Variant report
Variant | nsv979032 |
---|---|
Chromosome Location | chr2:87096093-87112321 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:40)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:40 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr2:87098162-87098330 | GM12878 | blood: | n/a | n/a |
2 | BCL11A | chr2:87098103-87098408 | GM12878 | blood: | n/a | n/a |
3 | BRCA1 | chr2:87101965-87102433 | Hela-S3 | cervix: | n/a | n/a |
4 | CEBPB | chr2:87100076-87100303 | A549 | lung: | n/a | chr2:87100117-87100130 |
5 | CTCF | chr2:87104375-87104398 | MCF-7 | breast: | n/a | n/a |
6 | CTCF | chr2:87099786-87099809 | GM10248 | blood: | n/a | n/a |
7 | EP300 | chr2:87102332-87102444 | K562 | blood: | n/a | n/a |
8 | FOS | chr2:87106144-87106346 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | FOSL2 | chr2:87110067-87110336 | HepG2 | liver: | n/a | n/a |
10 | FOSL2 | chr2:87096231-87096509 | HepG2 | liver: | n/a | n/a |
11 | FOXA1 | chr2:87095935-87096585 | HepG2 | liver: | n/a | chr2:87096107-87096119 |
12 | FOXA1 | chr2:87109935-87110572 | HepG2 | liver: | n/a | chr2:87110459-87110471 |
13 | FOXA1 | chr2:87096732-87097080 | HepG2 | liver: | n/a | n/a |
14 | HEY1 | chr2:87109266-87109488 | K562 | blood: | n/a | n/a |
15 | MAFF | chr2:87102084-87102424 | HepG2 | liver: | n/a | n/a |
16 | MAFF | chr2:87102211-87102411 | K562 | blood: | n/a | n/a |
17 | MAFK | chr2:87102057-87102417 | HepG2 | liver: | n/a | n/a |
18 | MXI1 | chr2:87104918-87105221 | GM12878 | blood: | n/a | n/a |
19 | MYBL2 | chr2:87109982-87110535 | HepG2 | liver: | n/a | n/a |
20 | POLR2A | chr2:87108578-87108737 | ProgFib | skin: | n/a | n/a |
21 | POLR2A | chr2:87104309-87104419 | MCF-7 | breast: | n/a | n/a |
22 | POLR2A | chr2:87109312-87109348 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr2:87103135-87103387 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr2:87109269-87109271 | MCF-7 | breast: | n/a | n/a |
25 | POLR2A | chr2:87104278-87104421 | Gliobla | brain: | n/a | n/a |
26 | POLR2A | chr2:87104321-87104425 | A549 | lung: | n/a | n/a |
27 | POLR2A | chr2:87109360-87109367 | MCF-7 | breast: | n/a | n/a |
28 | POLR2A | chr2:87108849-87108915 | MCF-7 | breast: | n/a | n/a |
29 | POLR2A | chr2:87104781-87105047 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | RXRA | chr2:87096062-87096457 | HepG2 | liver: | n/a | chr2:87096230-87096239 |
31 | RXRA | chr2:87095954-87096553 | HepG2 | liver: | n/a | chr2:87096230-87096239 |
32 | RXRA | chr2:87110056-87110557 | HepG2 | liver: | n/a | chr2:87110339-87110348 |
33 | RXRA | chr2:87110096-87110431 | HepG2 | liver: | n/a | chr2:87110339-87110348 |
34 | SIN3AK20 | chr2:87096240-87096437 | HepG2 | liver: | n/a | n/a |
35 | SIN3AK20 | chr2:87110137-87110303 | HepG2 | liver: | n/a | n/a |
36 | SPI1 | chr2:87107218-87107436 | GM12878 | blood: | n/a | n/a |
37 | SPI1 | chr2:87107239-87107410 | K562 | blood: | n/a | n/a |
38 | SPI1 | chr2:87107185-87107410 | GM12891 | blood: | n/a | n/a |
39 | STAT3 | chr2:87101126-87101410 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | TEAD4 | chr2:87095770-87096523 | HepG2 | liver: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ANAPC1P1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7370527 | chr2:87096095-87096096 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs199697940 | chr2:87096108-87096109 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs554989462 | chr2:87096167-87096168 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs193191126 | chr2:87096183-87096184 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs7371283 | chr2:87096193-87096194 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs534928257 | chr2:87096210-87096211 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs185461121 | chr2:87096216-87096217 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs71411878 | chr2:87096221-87096222 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs577762676 | chr2:87096243-87096244 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs541587276 | chr2:87096269-87096270 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs563278723 | chr2:87096289-87096290 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs575282578 | chr2:87096290-87096291 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs542242648 | chr2:87096314-87096315 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs560572274 | chr2:87096357-87096358 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs62146899 | chr2:87096389-87096390 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs62146900 | chr2:87096394-87096395 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
17 | rs201630203 | chr2:87096541-87096542 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs13423978 | chr2:87096581-87096582 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs565528519 | chr2:87096585-87096586 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs71411880 | chr2:87096587-87096588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150436469 | chr2:87096593-87096594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551146679 | chr2:87096614-87096615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569289633 | chr2:87096621-87096622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536724827 | chr2:87096643-87096644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548676949 | chr2:87096699-87096700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71411881 | chr2:87096757-87096758 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs566879158 | chr2:87096761-87096762 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs534133395 | chr2:87096786-87096787 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs553037725 | chr2:87096788-87096789 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs571507166 | chr2:87096794-87096795 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs6725174 | chr2:87096802-87096803 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
32 | rs557096636 | chr2:87096831-87096832 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs575067226 | chr2:87096833-87096834 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs180834145 | chr2:87096846-87096847 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs554204344 | chr2:87096867-87096868 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs572509099 | chr2:87096932-87096933 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs539839971 | chr2:87096933-87096934 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs377423082 | chr2:87096969-87096970 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs565483099 | chr2:87096978-87096979 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs6753738 | chr2:87097057-87097058 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs562809478 | chr2:87097078-87097079 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs544510579 | chr2:87097100-87097101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183624699 | chr2:87097152-87097153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374309344 | chr2:87097165-87097166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6743331 | chr2:87097187-87097188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs367779344 | chr2:87097198-87097199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188296563 | chr2:87097203-87097204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530274358 | chr2:87097216-87097217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs548701668 | chr2:87097223-87097224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181178217 | chr2:87097280-87097281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 20409316 | CNVD |
Breast cancer | 21990379 | CNVD |
Astrocytoma | 22246337 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Schizophrenia | 23813976 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:87095600-87096800 | Weak transcription | Fetal Thymus | thymus |
2 | chr2:87095800-87096200 | Enhancers | HepG2 | liver |
3 | chr2:87096800-87097400 | Enhancers | Fetal Thymus | thymus |
4 | chr2:87104200-87104800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |